Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Conditions

• Corona Virus Infection
• Covid19
• SARS-CoV Infection

Interventions

• DRUG: Placebo administration
• DIAGNOSTIC_TEST: Confirm SARS-CoV-2 infection
• PROCEDURE: Physical Examination
• PROCEDURE: Vital Signs
• DIAGNOSTIC_TEST: Hematology blood test
• DIAGNOSTIC_TEST: Biochemistry blood test
• OTHER: NEWS score
• DIAGNOSTIC_TEST: PK test
• DIAGNOSTIC_TEST: blood test for inflammatory markers
• DIAGNOSTIC_TEST: D-dimer test
• OTHER: VAS scale
• DIAGNOSTIC_TEST: Urine pregnancy test for women of childbearing potential
• PROCEDURE: ECG
• OTHER: COVID-19-Impact on Quality of Life Questionnaire
• DRUG: CimetrA-1
• DRUG: CimetrA-2

Sponsor

MGC Pharmaceuticals d.o.o